
==== Front
World J Radiol
WJR
World Journal of Radiology
1949-8470
Baishideng Publishing Group Inc

jWJR.v16.i8.pg362
10.4329/wjr.v16.i8.362
96254
Case Report
Pulmonary abscess caused by Streptococcus pseudopneumoniae in a child: A case report and review of literature
Ma R et al. Pulmonary abscess caused by Streptococcus pseudopneumoniae
Ma Ran Department of Pediatrics, Shihezi University, Shihezi 832000, Xinjiang Uygur Autonomous Region, China

Wang Yan-Mei Department of Pediatrics, The First Affiliated Hospital of Shihezi University, Shihezi 832000, Xinjiang Uygur Autonomous Region, China

Guan Hua Department of Pediatrics, Corps Fourth Division Hospital, Yining 844500, Xinjiang Uygur Autonomous Region, China

Zhang Li Department of Pediatrics, The First Affiliated Hospital of Shihezi University, Shihezi 832000, Xinjiang Uygur Autonomous Region, China

Zhang Wei Department of Pediatrics, The First Affiliated Hospital of Shihezi University, Shihezi 832000, Xinjiang Uygur Autonomous Region, China. zwxnh1@163.com

Chen Ling-Cai Department of Pediatrics, Corps First Division Hospital, Aksu 842008, Xinjiang Uygur Autonomous Region, China

Author contributions: Ma R contributed to manuscript writing, editing and making the audio; Zhang W contributed to conceptualization and supervision; Wang YM, Guan H, Zhang L, Chen LC contributed to supervision; all authors have read and approved the final manuscript.

Supported by Corps Guiding Plan Project of Xinjiang Uygur Autonomous Region, China, No. 2022ZD031; Financial Science and Technology Plan Project of Shihezi, Xinjiang Uygur Autonomous Region of China, No. 2022NY01; and Research Project of Shihezi University of Shihezi, Xinjiang Uygur Autonomous Region of China, No. ZZZC202072A.

Corresponding author: Wei Zhang, Doctor, MD, Associate Chief Physician, Department of Pediatrics, The First Affiliated Hospital of Shihezi University, No. 107 Beier Road, No. 32 district, Shihezi 832000, Xinjiang Uygur Autonomous Region, China. zwxnh1@163.com

28 8 2024
28 8 2024
16 8 362370
30 4 2024
5 8 2024
9 8 2024
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
2024
https://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
BACKGROUND

Lung abscess found on chest X-ray and computed tomography examinations is rare in infants and young children. Several pathogens can cause lung abscesses, with the most common pathogens being anaerobes, Streptococci and Staphylococcus aureus. Streptococcus pseudopneumoniae (S. pseudopneumoniae) is a member of the Streptococcaceae family, and is mainly isolated from respiratory tract specimens. There are currently no cases of lung abscess caused by S. pseudopneumoniae in the literature.

CASE SUMMARY

A 2-year-old boy was admitted to hospital due to persistent cough and fever. Lung computed tomography examination suggested the formation of a lung abscess. His diagnosis was not confirmed by testing for serum respiratory pathogens (6 items), respiratory pathogen nucleic acid (27 items), and laboratory culture. Finally, metagenomic next-generation sequencing of bronchoalveolar lavage fluid revealed the presence of S. pseudopneumoniae, confirming its role in causing the lung abscess. After receiving antibiotic treatment, reexamination with lung computed tomography showed that the abscess was resorbed and the patient’s outcome was good.

CONCLUSION

This is the first report of a lung abscess in a child caused by S. pseudopneumoniae infection. Metagenomic next-generation sequencing of bronchoalveolar lavage fluid is helpful in achieving rapid and accurate pathogen identification.

Streptococcus pseudopneumoniae
Lung abscess
Children
Bronchoalveolar lavage fluid
Metagenomic next-generation sequencing
Case report
==== Body
pmc Core Tip: This report describes a 2-year-old boy presenting with a lung abscess attributed to Streptococcus pseudopneumoniae (S. pseudopneumoniae) infection. Pulmonary abscess is uncommon in pediatric respiratory diseases, and can be caused by a variety of pathogens. Despite multiple etiological tests conducted upon admission, no pathogen was identified. Eventually, metagenomic next-generation sequencing (mNGS) of bronchoalveolar lavage fluid was employed and confirmed the presence of S. pseudopneumoniae. There are currently no reports of pulmonary abscess caused by S. pseudopneumoniae infection in the international literature. This case highlights the significance of mNGS in pulmonary infectious diseases, which is regarded as a complementary approach to conventional respiratory pathogen diagnostic techniques.

INTRODUCTION

Lung abscess is a rare disease in pediatrics and occurs when pathogens such as viruses, bacteria, fungi or parasitic pathogens invade the lung parenchyma, leading to lung tissue necrosis and the subsequent formation of a purulent cavity[1]. Clinically, lung abscess can be diagnosed by chest X-ray and computed tomography (CT) examinations[2,3]. A variety of pathogenic infections can trigger lung abscesses, with Streptococcus, Staphylococcus aureus, and anaerobes being the most common[2-4]. We searched the databases, including China National Knowledge Infrastructure, Cqvip Database, Wanfang Database, PubMed, Uptodate, and Web of Science, without language restrictions from their inception to January 28, 2024. We used the following keywords in the search: Streptococcus pseudopneumoniae (S. pseudopneumoniae) [Title/Abstract] AND Pulmonary Abscess [Title/ Abstract] OR Lung Abscess [Title/ Abstract], and did not find any cases of lung abscess caused by S. pseudopneumoniae infection. S. pseudopneumoniae and Streptococcus pneumoniae (S. pneumoniae) have high genetic similarity, and are difficult to identify only by phenotype and biomarkers. Studies have shown that S. pneumoniae and S. pseudopneumoniae can be distinguished by publicly-available genome sequences[5]. Patients with a lung abscess usually choose conservative treatment with intravenous antibiotics[3,6]. Several cases have shown that S. pseudopneumoniae, usually collected from respiratory tract samples, was resistant to penicillin, cephalosporin, macrolide, fluoroquinolone, and cotrimoxazole[7-10], and relying on empirical medication poses a significant risk of delayed diagnosis, potentially leading to life-threatening consequences.

We here report a case of a 2-year-old boy with lung abscess caused by S. pseudopneumoniae infection. On admission, pulmonary CT showed lung abscess, and general bacterial culture and identification, antibody detection, qPCR, tuberculosis smear of bronchoalveolar lavage fluid (BALF), and Mycoplasma pneumoniae-DNA in BALF did not identify the pathogen. Chinese clinical guidelines recommend that BAL by bronchoscopy is helpful in the diagnosis and treatment of pulmonary infectious diseases[11]. We finally obtained BALF and identified the pathogen by metagenomic next-generation sequencing (mNGS). Therefore, children with respiratory diseases whose pathogens cannot be identified by routine clinical testing should undergo BALF mNGS, which is helpful in achieving rapid and accurate pathogen identification[12].

CASE PRESENTATION

Chief complaints

A 2-year-old boy was admitted to The First Affiliated Hospital of Shihezi University due to a persistent cough for seven days and fever for five days.

History of present illness

The boy had symptoms of cough and fever, did not received any anti-infectious treatment outside the hospital.

History of past illness

The family denied any abnormal past illness history.

Personal and family history

The family denied any history of tuberculosis exposure or foreign body inhalation, and had normal birth history, feeding history, growth history and family history.

Physical examination

On admission, the patient’s body temperature was 40 °C, heart rate was 120 bpm, respiratory rate was 31 breaths/min, and blood pressure was 80/55 mmHg. Physical examination revealed hyperemia of the pharynx, bilateral tonsil enlargement (I-degree), and the absence of purulent secretions. Upon auscultation, there were thick breathing sounds in both lungs, but no dry-wet rales.

Laboratory examinations

Following admission, the patient’s laboratory tests indicators not improved (Table 1), routine blood testing showed the dominance of neutrophils, and the index of inflammation had increased significantly. Thus, we considered that the child had a bacterial infection. General bacterial culture, respiratory pathogen antigens (6 respiratory pathogens, IgM Antibody Detection Kit, Autobio, Zhengzhou, China), respiratory tract pathogen PCR (27 nucleic acid test kits for respiratory pathogens, Yingweipu, Zhejiang, China) all yielded normal results.

Table 1 Laboratory tests conducted after admission

Laboratory test	Results	Reference value	
WBC (L)	10.6 × 109	5.1-14.1 × 109	
Neutrophil count (L)	4.88 × 109 (46%)	0.8-5.8 × 109	
Lymphocyte count (L)	4.1 × 109 (38.7%)	2.4-8.7 × 109	
Monocyte count (L)	1.4 × 109 (12.8%)	0.18-1.13 × 109	
Hemoglobin (g/L)	106 g/L	107-141	
Platelet count (L)	354 × 109	190-524 × 109	
C-reactive protein (mg/L)	65.45	< 10	
Interleukin- 6 (pg/mL)	24.82	< 7.0	
Procalcitonin (ng/L)	0.85	< 0.05	
ESR (mm/h)	65	0-15	
Blood coagulation function test	Normal	Normal	
Immunoglobulin testing (5 items)	Normal	Normal	
Liver function	Normal	Normal	
Renal function	Normal	Normal	
Myocardial enzyme	Normal	Normal	
T-SPOT.TB, PPD, Tuberculosis smear (BALF)	Negative	Negative	
Pharynx swab, Blood, BALF culture	Negative	Negative	
Serum respiratory pathogen antibody (6 items)1	Negative	Negative	
Respiratory tract pathogen PCR (27 items)2	Negative	Negative	
Mycoplasma pneumoniae DNA (BALF)	< 1.0 × 104	< 1.0 × 104	
mNGS (BALF)	Pathogens: Streptococcus pseudopneumoniae: 36449 sequences. Human herpesvirus 5: 926 sequences. Human parainfluenza virus type 3: 2089 sequences	
Antibiotic resistance genes: No antibiotic resistance genes were detected	
Genes specific to Streptococcus pseudopneumoniae: Pseudo_232, 901, 231, 902, 899, 228, 1764, 641, 1933 (5)	
PLY gene	
1 The words in bold are obvious outliers. The six serum respiratory pathogens included Mycoplasma pneumoniae, Chlamydia pneumoniae, Legionella pneumophila, enterovirus, respiratory syncytial virus and adenovirus.

2 The 27 respiratory tract pathogens included Group B Streptococcus, H1N1 influenza A virus, H3N2 influenza A virus, H3 influenza A virus, H5 influenza A virus, H7 influenza A virus, pertussis bacterium, rhinovirus, Boca virus, Enterovirus, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, parainfluenza virus type 1, parainfluenza virus type 2, parainfluenza disease type 3, parainfluenza virus type 4, coronavirus, respiratory syncytial virus, Streptococcus pyogenes, influenza A virus, Moraxella catarrata, Haemophilus influenzae, human metapneumovirus, Legionella pneumophila, adenovirus, and influenza B virus.

WBC: White blood cell; ESR: Erythrocyte sedimentation rate; BALF: Bronchoalveolar lavage fluid; T-SPOT.TB: Tuberculosis-specific enzyme-linked immunospot assay; PPD: Purified protein derivative; PCR: Polymerase chain reaction.

On the third day of hospitalization, with informed consent from his family, the child underwent BAL to identity the pathogen, and the tracheoscope (Figure 1) revealed congestion and edema of the bronchial mucosa in the upper lobe of the right lung with a little viscous secretion. Phagocytes are dominant in normal BALF, and the proportion of neutrophils increases during bacterial infection. Pathological smears of the collected BALF (Figure 2) indicated the presence of markedly elevated neutrophils. Mycoplasma pneumoniae DNA in BALF was lower than the detected minimum value (Instructions for Mycoplasma pneumoniae nucleic acid detection kit, Daan Gene, Guangzhou, China) (Table 1). The collected pulmonary alveolar lavage fluid samples were subjected to Q-mNGS™ quantitative metagenomics (Dian Medical Laboratory, Zhejiang, China), and the bioinformatics process included: (1) Quality filtering; (2) Elimination of replicate reads; (3) Removal of low-complexity reads matching the human genome sequence; and (4) Classification of reads by simultaneously aligning to the NCBI Database. The mNGS of BALF revealed S. pseudopneumoniae, by comparing the sequence similarity between the sequencing fragment and the known drug resistance gene in the Comprehensive Antibiotic Resistance Database (Table 1).

Figure 1 Bronchoscopic findings. The tracheal mucosa of the upper lobe of the right lung is congested and edematous with a little sticky secretion.

Figure 2 Bronchoalveolar lavage fluid pathological smear. Smear showing neutrophils (90%), mononuclear phagocytes (9%), and lymphocytes (1%).

Imaging examinations

After admission, pulmonary CT revealed a lung abscess, and a follow-up lung CT scan revealed that the right upper lobe posterior lung abscess had discharged. A lung CT scan after hospital discharge revealed that the lung abscess had been absorbed (Figure 3).

Figure 3 Computed tomography findings. A: Computed tomography (CT) scan showing inflammation of the posterior upper lobe of the right lung with abscess formation on September 2; B: CT scan showing an abscess in the posterior segment of the upper lobe of the right lung on September 8, which was more noticeable than that around the abscess on September 2; C: CT scan on September 22, showing the cystic cavity structure of the posterior segment of the upper lobe of the right lung, which was more absorbed than that around the film on September 8; D: CT scan showing focal pneumonitis in the posterior segment of the right upper lobe on October 9; Compared to the film on September 22, the thin-walled transparent focus of the posterior segment of the right upper lobe disappeared, and mild bronchitis was found in both lungs.

FINAL DIAGNOSIS

The mNGS suggested two types of viruses, but the number of detected sequences was low and the disease course was long; thus, S. pseudopneumoniae infection was considered. Taking into account the clinical manifestations, the mNGS test, CT findings, and the therapeutic effect of antibiotics, the patient was diagnosed with pulmonary abscess caused by S. pseudopneumoniae infection.

TREATMENT

Treatment was initiated by administering empirical parenteral antibiotics, which was ceftazidime. His temperature returned to normal after 3 days of treatment, but his cough was still serious. Following BAL, the patient’s cough was significantly relieved. Under ceftazidime treatment, the child’s clinical symptoms improved, and S. pseudopneumoniae was considered sensitive to ceftazidime.

OUTCOME AND FOLLOW-UP

Reexamination of the lung by CT showed that the abscess had been resorbed and the patient’s outcome was good. Table 2 indicated the timeline of the patient’s course of illness.

Table 2 Timeline of patient’ s course of illness

Date	Symptoms onset	Imaging examination	Treatments administered	Follow-up outcomes	
August 30, 2023	Persistent cough for seven days and fever for five days	None	Ceftazidime was given for anti-infective treatment	Temperature returned to normal	
September 2, 2023	Temperature was normal, but cough was still serious	Pulmonary CT	Continue anti-infective treatment	Inflammation of the posterior upper lobe of the right lung with abscess formation	
September 4, 2023	The frequency of coughing slightly decreased	None	Bronchoalveolar lavage	The frequency of coughing decreased.	
September 8, 2023	The frequency of coughing obviously disappeared	Pulmonary CT	Continue anti-infective treatment		
September 14, 2023	None	None	Cefdinil was given for anti-infective treatment	Hospital discharge	
October 9, 2023	None	Pulmonary CT	None	The abscess was resorbed and the patient’s outcome was good	
CT: Computed tomography.

DISCUSSION

Lung abscess in children is a very rare condition that significantly reduces their quality of life. Children with lung abscesses may present with fever, fatigue, cough, shortness of breath, and chest pain[13]. In the case of the child described here, the focus was confirmed by transpulmonary CT. Empirical antibiotic treatment is commonly the initial therapeutic option for lung abscesses. However, in some cases, the specific pathogen is never identified, resulting in poor treatment outcome. Lung abscesses can be attributed to a diverse range of infectious pathogens, with Streptococcus and anaerobes being the most frequently encountered in clinical settings. However, there are numerous cases where the specific pathogen responsible for the infection remains unclear.

In the present case, the pathogen could not be identified by general bacterial culture and identification, indicating that the positive rate of this strain was low; as qPCR has the limitation of only detecting targeted pathogens, 27 common respiratory pathogens were found negative after admission, and no pathogens were isolated from blood or BALF culture. These findings further supported the crucial role of mNGS in confirming S. pseudopneumoniae infection. This highlights the potential oversight and misdiagnosis of infections caused by pathogens such as S. pseudopneumoniae. S. pseudopneumoniae, which was first reported in 2004, is closely related to the main human pathogen S. pneumoniae. It belongs to the Streptococcaceae family and is characterized by the absence of a capsule, insolubility in bile, and resistance to optochin under 50 mL/L CO2 conditions[14,15]. The appearance of sputum Gram staining smears in patients with S. pseudopneumoniae infection is similar to that of those with S. pneumoniae. The historical challenge in the detection of S. pseudopneumoniae using classical microbiological methods such as the optochin sensitivity test and bile solubility test resulted in a low detection rate[16]. Dupont et al[17] preliminarily identified 20 strains of S. pseudopneumoniae using routine methods, among these, 7 strains were identified as S. pneumoniae by Matrix-Assisted Laser Desorption Ionization Time of Flight mass spectrometry (VITEK MS®, bioMérieux). Gonzales-Siles et al[5] analyzed the gene sequence of the Streptococcaceae family and found that 9 genes were specific to S. pseudopneumoniae and 10 genes were specific to S. pneumoniae, these specific genes can be considered as potential gene biomarkers of these species. Following mNGS, nine of the S. pseudopneumoniae gene markers were also observed in the present case. Therefore, based on the phenotypic characteristics of S. pseudopneumoniae, genotyping methods such as PCR and gene sequencing are helpful for accurate identification[15,18]. In this study, the BALF sample was sequenced on the Nanopore Gridion platform, and the sequencing results were further verified using the NCBI database to distinguish between S. pneumoniae and S. pseudopneumoniae (Figure 4). There is a file on the methods used and information on the mNGS procedure in the attachment.

Figure 4 Information of metagenomic next-generation sequencing. The abscissa is the expansion subregion, and the ordinate is the sequence number multiplied by the sequencing length 50. Gene number of Streptococcus pseudopneumoniae: CP002925.1, information on the metagenomic next-generation sequencing is shown in the supplementary file.

S. pseudopneumoniae belongs to the Streptococcaceae family and is invasive. A study demonstrated that S. pseudopneumoniae can cause peritonitis/septicemia in mice[19]. Upon invading the respiratory tract, the strain’s surface protein PspK plays a pivotal role in promoting colonization within the respiratory epithelial cells, leading to initiation of the infection process[20]. Virulence gene PLY in S. pseudopneumoniae kills various types of cells through pore-forming cytolytic activity. This activity not only triggers the activation of inflammatory responses but also exacerbates pulmonary inflammation[5,9,21-22]. In the context of the present case, the development of lung abscess attributed to S. pseudopneumoniae may be related to this mechanism. Some studies have reported that S. pseudopneumoniae infection leads to meningitis[23,24], and this association may be attributed to the role of PLY in promoting the transport of bacteria across the blood-brain barrier[25].

S. pseudopneumoniae, as an opportunistic pathogen, mainly causes respiratory infections. S. pseudopneumoniae can cause infection resulting in or aggravating chronic respiratory diseases. Ren et al[26] obtained BALF from patients with bronchiectasis and pulmonary infection for mNGS, and mNGS detected S. pseudopneumoniae, S. pneumoniae, and Staphylococcus aureus. Laurens et al[27] analyzed respiratory tract samples from 38 patients with pneumonia complicated by S. pseudopneumoniae infection, including 5 cases with single detection of S. pseudopneumoniae and 16 cases with detection of S. pseudopneumoniae, Staphylococcus aureus, and Haemophilus influenzae. In the present case, the diagnosis, confirmed by mNGS, showed lung abscess with S. pseudopneumoniae, human parainfluenza virus and human herpes virus, underscoring the occurrence of simultaneous detection involving S. pseudopneumoniae.

As a supplement to traditional methods, mNGS has a higher positive rate, higher sensitivity, and a wider pathogen spectrum[28], and has a diagnostic advantage in patients undergoing empirical treatment[29]. Therefore, it has obvious advantages in shortening the time to pathogen diagnosis and appropriate anti-infective treatment, and can greatly improve the prognosis of patients. However, the interpretation of results requires the help of experts, consolidation of clinical indicators, sample types, pathogen types and other factors, which makes the current application of mNGS in clinical detection controversial. This is why S. pseudopneumoniae, one of the three pathogens detected by mNGS, is considered the causative agent in this study.

In addition to intrapulmonary diseases, some cases of extrapulmonary diseases caused by S. pseudopneumoniae have been reported, including myocarditis and meningitis in newborns infected with S. pseudopneumoniae[23], recurrent tonsillitis caused by S. pseudopneumoniae infection in adolescents[30], and delayed blister-associated endophthalmitis in middle-aged patients with S. pseudopneumoniae infection[31]. Fuursted et al[32] noted that S. pseudopneumoniae infection in elderly patients can be secondary to sepsis associated with liver or bile-duct infections. Some middle-aged and elderly people may suffer from meningitis after S. pseudopneumoniae infection[24]. This case study revealed that S. pseudopneumoniae infection can lead to lung abscesses in young children. Thus, S. pseudopneumoniae infection can occur in all age groups.

It is reported that tetracycline and macrolide resistance are the two most common types of drug resistance[7]. Ghandi et al[23] reported that a neonate with meningitis and myocarditis caused by S. pseudopneumoniae was sensitive to erythromycin and azithromycin. In the present case, the comprehensive antibiotic resistance gene test did not detect the existence of any drug resistance genes, and the child was treated with ceftazidime on admission, and the therapeutic response was excellent, indicating that S. pseudopneumoniae was sensitive to ceftazidime. Therefore, children with S. pseudopneumoniae infection can be treated with macrolides and cephalosporins to observe the efficacy of these drugs.

CONCLUSION

S. pseudopneumoniae infection can cause lung abscesses. Clinically, in addition to symptomatic treatment, the causative microorganisms need to be identified promptly in patients with lung abscesses. In cases where routine laboratory examinations fail to identify the pathogen, advanced techniques such as serological antibody testing, PCR, and mNGS techniques could be employed. For instance, where pathogens have been identified, and targeted antibiotic treatments have not yielded satisfactory results, it is advisable to expedite the examination of drug-resistant genes. This allows for the selection of medications to which the infecting pathogen is not resistant, avoiding prolongation of the disease and an unfavorable prognosis. The use of mNGS has guiding significance in the discovery of atypical pathogens and the implementation of appropriate treatment.

Informed consent statement: The patients provided informed consent for publication of the case.

Conflict-of-interest statement: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).

Provenance and peer review: Unsolicited article; Externally peer reviewed.

Peer-review model: Single blind

Specialty type: Radiology, nuclear medicine and medical imaging

Country of origin: China

Peer-review report’s classification

Scientific Quality: Grade B

Novelty: Grade A

Creativity or Innovation: Grade A

Scientific Significance: Grade B

P-Reviewer: Liu Y S-Editor: Liu H L-Editor: A P-Editor: Yuan YY
==== Refs
1 Hillejan L [Management of Lung Abscess - Diagnostics and Treatment] Zentralbl Chir 2020 145 597 609 33260228
2 Yousef L Yousef A Al-Shamrani A Lung Abscess Case Series and Review of the Literature Children (Basel) 2022 9
3 Fernando DT Bhatt R Saiganesh A Schultz A Gera P Lung abscess: 14 years of experience in a tertiary paediatric hospital ANZ J Surg 2022 92 1850 1855 35678219
4 Marra A Hillejan L Ukena D [Management of Lung Abscess] Zentralbl Chir 2015 140 Suppl 1 S47 S53 26351764
5 Gonzales-Siles L Karlsson R Schmidt P Salvà-Serra F Jaén-Luchoro D Skovbjerg S Moore ERB Gomila M A Pangenome Approach for Discerning Species-Unique Gene Markers for Identifications of Streptococcus pneumoniae and Streptococcus pseudopneumoniae Front Cell Infect Microbiol 2020 10 222 32509595
6 Feki W Ketata W Bahloul N Ayadi H Yangui I Kammoun S [Lung abscess: Diagnosis and management] Rev Mal Respir 2019 36 707 719 31202603
7 Garriss G Nannapaneni P Simões AS Browall S Subramanian K Sá-Leão R Goossens H de Lencastre H Henriques-Normark B Genomic Characterization of the Emerging Pathogen Streptococcus pseudopneumoniae mBio 2019 10
8 Mohammadi JS Dhanashree B Streptococcus pseudopneumoniae: an emerging respiratory tract pathogen Indian J Med Res 2012 136 877 880 23287138
9 Sayed ZI Abdel-Ghany MF Ahmed SH Adawy AM El-Hamid RFA Streptococcus pseudopneumoniae as an emerging respiratory tract pathogen at Assiut University hospitals Iran J Microbiol 2022 14 645 652 36531811
10 Alvarado M Martín-Galiano AJ Ferrándiz MJ Zaballos Á de la Campa AG Upregulation of the PatAB Transporter Confers Fluoroquinolone Resistance to Streptococcus pseudopneumoniae Front Microbiol 2017 8 2074 29123510
11 Experts Group of Pediatric Respiratory Endoscopy, Talent Exchange Service Center of National Health Commission. [Guideline of pediatric flexible bronchoscopy in China] Shiyong Erke Linchuang Zazhi 2018 33 983 989
12 Li N Ma X Zhou J Deng J Gu C Fei C Cao L Zhang Q Tao F Clinical application of metagenomic next-generation sequencing technology in the diagnosis and treatment of pulmonary infection pathogens: A prospective single-center study of 138 patients J Clin Lab Anal 2022 36 e24498 35622934
13 Moral L Rabaneda L Toral T Calabuig E [Lung abscess in children] Open Respir Arch 2021 3 100085 37497071
14 Moreno C [Streptococcus pseudopneumoniae] Rev Chilena Infectol 2010 27 45 46 20140314
15 Shahinas D Thornton CS Tamber GS Arya G Wong A Jamieson FB Ma JH Alexander DC Low DE Pillai DR Comparative Genomic Analyses of Streptococcus pseudopneumoniae Provide Insight into Virulence and Commensalism Dynamics PLoS One 2013 8 e65670 23840352
16 Keith ER Podmore RG Anderson TP Murdoch DR Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples J Clin Microbiol 2006 44 923 927 16517877
17 Dupont C Michon AL Normandin M Salom G Latypov M Chiron R Marchandin H Streptococcus pseudopneumoniae, an opportunistic pathogen in patients with cystic fibrosis J Cyst Fibros 2020 19 e28 e31 31759908
18 Sadowy E Hryniewicz W Identification of Streptococcus pneumoniae and other Mitis streptococci: importance of molecular methods Eur J Clin Microbiol Infect Dis 2020 39 2247 2256 32710352
19 Harf-Monteil C Granello C Le Brun C Monteil H Riegel P Incidence and pathogenic effect of Streptococcus pseudopneumoniae J Clin Microbiol 2006 44 2240 2241 16757628
20 Keller LE Jones CV Thornton JA Sanders ME Swiatlo E Nahm MH Park IH McDaniel LS PspK of Streptococcus pneumoniae increases adherence to epithelial cells and enhances nasopharyngeal colonization Infect Immun 2013 81 173 181 23115034
21 Nishimoto AT Rosch JW Tuomanen EI Pneumolysin: Pathogenesis and Therapeutic Target Front Microbiol 2020 11 1543 32714314
22 Zafar MA Wang Y Hamaguchi S Weiser JN Host-to-Host Transmission of Streptococcus pneumoniae Is Driven by Its Inflammatory Toxin, Pneumolysin Cell Host Microbe 2017 21 73 83 28081446
23 Ghandi Y Ghanbari Sheldareh V Alinejad S Habibi D Myocarditis and meningitis during early sepsis in a neonate with Streptococcus pseudopneumoniae: a case report Iran J Neonatol 2018 9
24 Garriss G Wimmercranz Marking U Nannapaneni P Henriques-Normark B Blomqvist K A case of meningitis caused by Streptococcus pseudopneumoniae in Sweden Clin Microbiol Infect 2023 29 944 946 36966987
25 Zysk G Schneider-Wald BK Hwang JH Bejo L Kim KS Mitchell TJ Hakenbeck R Heinz HP Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelial cells caused by Streptococcus pneumoniae Infect Immun 2001 69 845 852 11159977
26 Ren JY Su YY Kang XW [Application of metagenomic next-generation sequencing in the diagnosis of bacterial flora in patients with pulmonary infection secondary to bronchiectasis] Zhonghua Shiyong Zhenduan Yu Zhiliao Zazhi 2022 36 849 51
27 Laurens C Michon AL Marchandin H Bayette J Didelot MN Jean-Pierre H Clinical and antimicrobial susceptibility data of 140 Streptococcus pseudopneumoniae isolates in France Antimicrob Agents Chemother 2012 56 4504 4507 22644030
28 Chen H Zhang Y Zheng J Shi L He Y Niu Y Lei J Zhao Y Xia H Chen T Application of mNGS in the Etiological Diagnosis of Thoracic and Abdominal Infection in Patients With End-Stage Liver Disease Front Cell Infect Microbiol 2021 11 741220 35071029
29 Zhang Y Cui P Zhang HC Wu HL Ye MZ Zhu YM Ai JW Zhang WH Clinical application and evaluation of metagenomic next-generation sequencing in suspected adult central nervous system infection J Transl Med 2020 18 199 32404108
30 Jensen A Fagö-Olsen H Sørensen CH Kilian M Molecular mapping to species level of the tonsillar crypt microbiota associated with health and recurrent tonsillitis PLoS One 2013 8 e56418 23437130
31 Kawakami H Nakane Y Inuzuka H Fukagawa T Muto T Mochizuki K Ohkusu K Suematsu H Yamagishi Y Mikamo H Late-onset bleb-related endophthalmitis caused by Streptococcus pseudopneumoniae Int Ophthalmol 2014 34 643 646 23884602
32 Fuursted K Littauer PJ Greve T Scholz CF Septicemia with Streptococcus pseudopneumoniae: report of three cases with an apparent hepatic or bile duct association Infect Dis (Lond) 2016 48 636 639 27100044
